Clarus Therapeutics Holdings Inc
|Market Cap (Intraday)||20.66M|
|2yr Forward PE||N/A|
Clarus Therapeutics Holdings Inc Stock, NASDAQ:CRXT
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Northbrook, IL.